Annidis Corporation is engaged in the research, development and sale of a medical device to eye-care professionals in Canada and the United States. The Company provides technology for early stage diagnosis of eye disease and develops instrumentation to assist in the early detection and monitoring of diseases of the eye. The Company�s RHA is an ocular pathology management system that integrates advanced multi-spectral imaging and analytic software for early detection and management of ocular pathologies, such as glaucoma, age related macular degeneration and diabetic retinopathy. The Company has also developed an imaging platform technology based on Multi-Spectral Imaging (MSI). MSI technology allows eye-care professionals to view non-invasively the deepest areas of the eye and provides for earlier identification and the treatment of debilitating eye diseases. Effective January 1, 2014, Annidis Corporation amalgamated with its wholly owned subsidiary Annidis Health Systems Corp.